CE InformationDownload MaterialsCourse Progress
  • Access Microlearning
  • Evaluation
  • Certificate
Evaluation

Putting it All Together in Bipolar Disorder: Personalizing Treatment in Bipolar Disorder (Module 4)

Evaluation

HMP Education would appreciate your feedback on the quality and impact of this activity.

Please answer the following questions, some of which include a 5-point Likert scale (5 = strongly agree/excellent/great deal; 1 = strongly disagree/poor/very little).

Did this activity meet your educational needs?
Did this activity increase your competence?
Do you feel like there were any new data presented during this activity?

Did you learn anything new?

Did you gain confidence in your ability to act on the new information?

Did this activity include opportunities to learn as a part of a healthcare team?

Please answer the following question using a 5-point likert scale (5 = a great deal, 3 = a modest amount, 1 = nothing at all).

How much did you learn as a result of this session?

Please rate the following components related to this activity using a 5-point likert scale (5 = excellent, 3 = good, 1 = poor).

Content
Relevance to your practice 
Educational format 
Overall

Please rate the faculty on their knowledge, expertise, and teaching ability (5= excellent, 3 = good, 1 = poor).

Julie Carbray, PhD, APRN, FPMHNP-BC
Greg Mattingly, MD

To what extent were the following learning objectives addressed by this activity (5 = entirely, 3 = moderately, 1 = not at all)?

Evaluate the potential of newer/novel therapies to mitigate cardiometabolic adverse effects in patients with bipolar disorder
Implement personalized strategies in routine care to minimize the rate of relapse/treatment nonadherence and improve outcomes in patients with bipolar disorder
The information presented in this activity was free of commercial bias.
How many patients do you encounter with bipolar disorder on a weekly basis?

Please now rate your ability to use currently available therapies to manage bipolar disorder.

Based on my participation in this activity, I anticipate I will more often: (select all that apply)
Which of the following statements is TRUE regarding treatment with samidorphan and olanzapine?
How confident are you now in your ability to implement personalized treatment strategies for patients with BD to minimize the rate of relapse/treatment nonadherence and improve outcomes?

Do you intend to make any additional changes to your practice as a result of information gained from this activity? Please be specific.

Which of the following barriers do you perceive in your efforts to implement practice changes and/or optimize patient care? Select all that apply.
255 characters max